MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-14-2023
Adamis Pharmaceuticals Corporation Operating Cycle 2011-2026 | ADMP
Annual Operating Cycle Adamis Pharmaceuticals Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 121 | 252 | 100 | 79.6 | 150 | 113 | 116 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 252 | 79.6 | 133 |
Quarterly Operating Cycle Adamis Pharmaceuticals Corporation
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 179 | 48.6 | - | 82 | 1.77 K | 106 | - | 186 | 210 | 141 | - | 210 | 86.1 | 93.1 | - | 76.2 | 81 | 95.4 | - | 158 | 152 | 141 | - | 22.4 | 19.9 | 24.6 | - | 35.4 | 38.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.77 K | 19.9 | 180 |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
152 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M |  Irlanda |
 |
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
614 | $ 3.18 | 1.76 % | $ 44.7 M | USA |
 |
Cronos Group
CRON
|
425 | $ 2.57 | - | $ 1.33 B |  Canada |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
78.9 | $ 5.69 | -0.61 % | $ 2.08 B | Canada |
 |
Harrow Health
HROW
|
217 | $ 37.93 | 2.24 % | $ 1.39 B | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.56 | 2.16 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
230 | $ 1.09 | 0.93 % | $ 117 M | Canada |
 |
Jupiter Wellness
JUPW
|
112 | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.44 | 1.06 % | $ 402 M | Canada |
 |
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
134 | $ 4.44 | 2.54 % | $ 286 M | USA |
 |
Emergent BioSolutions
EBS
|
237 | $ 8.66 | 5.1 % | $ 443 M | USA |
 |
Tilray
TLRY
|
222 | $ 6.92 | 2.9 % | $ 4.28 B | Canada |
 |
Organogenesis Holdings
ORGO
|
159 | $ 2.49 | 4.62 % | $ 328 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 23.78 | -1.16 % | $ 1.1 B | USA |
 |
Veru
VERU
|
271 | $ 2.38 | - | $ 321 M | USA |
 |
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | USA |
 |
Viatris
VTRS
|
219 | $ 13.95 | 0.83 % | $ 16.7 B | USA |
 |
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
590 | $ 18.02 | 0.03 % | $ 115 M | USA |
 |
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
176 | $ 0.73 | -1.49 % | $ 3.15 M | USA |
 |
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 1.02 | 1.49 % | $ 50.9 M | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
182 | $ 2.18 | -7.4 % | $ 2.71 M | USA |
 |
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
72.5 | $ 0.92 | -2.12 % | $ 33.1 M | USA |
 |
China Pharma Holdings
CPHI
|
187 | $ 0.63 | -3.05 % | $ 2.7 M |  China |
 |
TherapeuticsMD
TXMD
|
3.34 K | $ 2.14 | 4.39 % | $ 24.8 M | USA |